Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Trial of Rice-Based Oral Cholera Vaccine CUH-MR2601 in Healthy Adults
jRCT2031260408Phase 1Recruiting
- Start
- Sep 2026
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial in cholera comparing CUH-MR2601 vaccine with Wild rice placebo (2 arms). Primary endpoint: Safety and tolerability of CUH-MR2601. Started Sep 2026; status: recruiting.
02
Drugs
MucoRice-CTB
03
Conditions
cholera
Beyond the preview
Go deeper on jRCT2031260408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031260408.